Cited by 405Ovarian function and disordersReproductive Biology and FertilitySexual Differentiation and Disorders

The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.

The Biochemical Basis for Increased Testosterone Production in Theca Cells Propagated from Patients with Polycystic Ovary Syndrome

Nelson, Velen L., Qin, Ke-nan, Rosenfield, Robert L., Wood, Jennifer R., Penning, Trevor M., Legro, Richard S., Strauss, Jerome F., McAllister, Jan M.·2001·The Journal of Clinical Endocrinology & Metabolism

DOI 10.1210/jcem.86.12.8088

Open this paper in CoChat — free account

Abstract

Ovarian theca cells propagated from patients with polycystic ovary syndrome (PCOS) convert steroid precursors into T more efficiently than normal theca cells. To identify the basis for increased T production by PCOS theca cells, we examined type I-V 17 beta-hydroxysteroid dehydrogenase (17 beta HSD) isoform expression in long-term cultures of theca and granulosa cells isolated from normal and PCOS ovaries. RT-PCR analysis demonstrated that theca cells express type V 17 beta HSD a member of the aldo-keto reductase (AKR) superfamily (17 beta HSDV, AKR1C3), whereas expression of type I, II, and IV 17 beta HSD, which are members of the short-chain dehydrogenase/reductase superfamily, was limited to granulosa cells. Type III 17 beta HSD, the testicular isoform, was not detected in either granulosa or theca cells. Northern and real-time PCR analyses demonstrated that 17 beta HSDV transcripts were not significantly increased in PCOS theca cells compared with normal theca cells. RT-PCR analysis revealed that theca cells also express another AKR, 20 alpha HSD (AKR1C1). Both basal and forskolin-stimulated 20 alpha HSD mRNA levels were increased in PCOS theca cells compared with normal theca cells. However, 17 beta HSD enzyme activity per theca cell was not significantly increased in PCOS, suggesting that neither AKR1C3 nor AKR1C1 contributes to the formation of T in this condition. In contrast, 17 alpha-hydroxylase/C17,20 lyase and 3 beta HSD enzyme activities were elevated in PCOS theca cells, driving increased production of T precursors. These findings indicate that 1) increased T production in PCOS theca cells does not result from dysregulation of "androgenic" 17 beta HSD activity or altered expression of AKRs that may express 17 beta HSD activity; and 2) increased synthesis of T precursors is the primary factor driving enhanced T secretion in PCOS.

Integrity signals

Registry

Crossref · 10.1210/jcem.86.12.8088

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Decreases in Ovarian Cytochrome P450c17α Activity and Serum Free Testosterone after Reduction of Insulin Secretion in Polycystic Ovary Syndrome
Nestler, J. E., & Jakubowicz, D. J. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350902 · Cited by 743
Evidence for a genetic basis for hyperandrogenemia in polycystic ovary syndrome
Legro, R. S., Driscoll, D., Strauss, J. F., Fox, J., & Dunaif, A. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.25.14956 · Cited by 699
Self-citation
REVIEW ARTICLE: THE POLYCYSTIC OVARY SYNDROME
Yen, S. S. C. (1980) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1980.tb02132.x · Cited by 697
Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones
PENNING, T. M., BURCZYNSKI, M. E., JEZ, J. M., HUNG, C.-F., LIN, H.-K., MA, H., MOORE, M., PALACKAL, N., & RATNAM, K. (2000) · Biochemical Journal · doi:10.1042/bj3510067 · Cited by 649
Self-citation
Male pseudohermaphroditism caused by mutations of testicular 17β-hydroxysteroid dehydrogenase 3
Geissler, W. M., Davis, D. L., Wu, L., Bradshaw, K. D., Patel, S., Mendonca, B. B., Elliston, K. O., Wilson, J. D., Russell, D. W., & Andersson, S. (1994) · Nature Genetics · doi:10.1038/ng0594-34 · Cited by 570
The Ovarian Androgen Producing Cells: A Review of Structure/Function Relationships1,2
Erickson, G. F., Magoffin, D. A., Dyer, C. A., & Hofeditz, C. (1985) · Endocrine Reviews · doi:10.1210/edrv-6-3-371 · Cited by 569
Augmented androgen production is a stable steroidogenic phenotype of propagated theca cells from polycystic ovaries
Nelson, V. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (1999) · Molecular Endocrinology · doi:10.1210/mend.13.6.0311 · Cited by 556
Self-citation
Polycystic Ovary Syndrome as a Form of FunctionalOvarian Hyperandrogenism Due to Dysregulation ofAndrogen Secretion*
EHRMAN, D. A., Barnes, R. B., & Rosenfield, R. L. (1995) · Endocrine Reviews · doi:10.1210/edrv-16-3-322 · Cited by 498
Self-citation
Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion
Ehrmann, D. A. (1995) · Endocrine Reviews · doi:10.1210/er.16.3.322 · Cited by 394
The Polycystic Ovary. I. Clinical and Histologic Features
Goldzieher, J. W., & Green, J. (1962) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-22-3-325 · Cited by 369

Show all 42 references

Research works printed but not linked: 2

Zawadzki, 1992, Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach, In: Dunaif A, Givens JR, Haseltine FP, Merriam G, eds. Current issues in endocrinology and metabolism. Polycystic ovary syndrome. Boston: Blackwell;, 377
McAllister, 1993, Human theca interna cells in culture, In: Heindel J, Chapin R, eds. Methods in toxicology. San Diego: Academic Press;, 330

Sorted by citations

Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Polycystic Ovary Syndrome
Ehrmann, D. A. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041536 · Cited by 1,917
The pathogenesis of polycystic ovary syndrome (PCOS): the hypothesis of PCOS as functional ovarian hyperandrogenism revisited
Rosenfield, R. L., & Ehrmann, D. A. (2016) · Endocrine Reviews · doi:10.1210/er.2015-1104 · Cited by 1,603
Self-citation
Follicle dynamics and anovulation in polycystic ovary syndrome
Franks, S., Stark, J., & Hardy, K. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn015 · Cited by 581
The follicular excess in polycystic ovaries, due to intra-ovarian hyperandrogenism, may be the main culprit for the follicular arrest
Jonard, S. (2004) · Human Reproduction Update · doi:10.1093/humupd/dmh010 · Cited by 513
A New Rat Model Exhibiting Both Ovarian and Metabolic Characteristics of Polycystic Ovary Syndrome
Mannerås, L., Cajander, S. B., Holmäng, A. B., Seleskovic, Z., Lystig, T., Lönn, M., & Stener‐Victorin, E. (2007) · Endocrinology · doi:10.1210/en.2007-0168 · Cited by 488
Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence
Qiao, J., & Feng, H. L. (2011) · Human Reproduction Update · doi:10.1093/humupd/dmq032 · Cited by 479
The Molecular-Genetic Basis of Functional Hyperandrogenism and the Polycystic Ovary Syndrome
Escobar-Morreale, H. F., Luque‐Ramírez, M., & Millán, J. L. S. (2005) · Endocrine Reviews · doi:10.1210/er.2004-0004 · Cited by 426
Direct Insulin and Leptin Action on Pro-opiomelanocortin Neurons Is Required for Normal Glucose Homeostasis and Fertility
Hill, J. W., Elias, C. F., Fukuda, M., Williams, K. W., Berglund, E. D., Holland, W. L., Cho, Y.-R., Chuang, J.-C., Xu, Y., Choi, M., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.03.002 · Cited by 391
The Polycystic Ovary Syndrome Associated with Morbid Obesity May Resolve after Weight Loss Induced by Bariatric Surgery
Escobar-Morreale, H. F., Botella-Carretero, J. I., Álvarez‐Blasco, F., Sancho, J., & Millán, J. L. S. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-1490 · Cited by 389
Endocrine Disruptors and Polycystic Ovary Syndrome (PCOS): Elevated Serum Levels of Bisphenol A in Women with PCOS
Kandaraki, E., Chatzigeorgiou, A., Livadas, S., Palioura, E., Economou, F., Koutsilieris, M., Palimeri, S., Panidis, D., & Diamanti‐Kandarakis, E. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2010-1658 · Cited by 402
Prevalence and Characteristics of the Polycystic Ovary Syndrome in Overweight and Obese Women
Álvarez‐Blasco, F., Botella-Carretero, J. I., Millán, J. L. S., & Escobar-Morreale, H. F. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.19.2081 · Cited by 352
Characterization of the Hypothalamic-Pituitary-Gonadal Axis in Estrogen Receptor (ER) Null Mice Reveals Hypergonadism and Endocrine Sex Reversal in Females Lacking ERα But Not ERβ
Couse, J. F., Yates, M. M., Walker, V. R., & Korach, K. S. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0398 · Cited by 314
Molecular Abnormalities in Oocytes from Women with Polycystic Ovary Syndrome Revealed by Microarray Analysis
Wood, J. R., Dumesic, D. A., Abbott, D. H., & Strauss, J. F. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-2123 · Cited by 310
Self-citation
Autophagy in ovary and polycystic ovary syndrome: role, dispute and future perspective
Kumariya, S., Ubba, V., Jha, R. K., & Gayen, J. R. (2021) · Autophagy · doi:10.1080/15548627.2021.1938914 · Cited by 306
Polycystic ovary syndrome: Syndrome XX?
Sam, S., & Dunaif, A. E. (2003) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2003.08.002 · Cited by 302
Human skin is a steroidogenic tissue: steroidogenic enzymes and cofactors are expressed in epidermis, normal sebocytes, and an immortalized sebocyte cell line (SEB-1)
Thiboutot, D., Gilliland, K., Cong, Z., Jabara, S., McAllister, J. M., Sivarajah, A., & Clawson, G. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12244.x · Cited by 301
Self-citation
Deconstructing a Syndrome: Genomic Insights Into PCOS Causal Mechanisms and Classification
Dapas, M., & Dunaif, A. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnac001 · Cited by 300
The pathophysiology of polycystic ovary syndrome
Tsilchorozidou, T., Overton, C. E., & Conway, G. S. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01842.x · Cited by 295
Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome
Leo, V. D., Marca, A. L., & Petraglia, F. (2003) · Endocrine Reviews · doi:10.1210/er.2002-0015 · Cited by 291
Polycystic ovary syndrome and its developmental origins
Dumesic, D. A., Abbott, D. H., & Padmanabhan, V. (2007) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-007-9046-0 · Cited by 283
The Molecular Phenotype of Polycystic Ovary Syndrome (PCOS) Theca Cells and New Candidate PCOS Genes Defined by Microarray Analysis
Wood, J. R., Nelson-DeGrave, V. L., Ho, C. K. M., Jansen, E., Wang, C. Y., Urbanek, M., McAllister, J. M., Mosselman, S., & Strauss, J. F. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m300688200 · Cited by 259
Self-citation
Overexpression of a DENND1A isoform produces a polycystic ovary syndrome theca phenotype
McAllister, J. M., Modi, B., Miller, B. A., Biegler, J., Bruggeman, R., Legro, R. S., & Strauss, J. F. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1400574111 · Cited by 250
Self-citation
Functional genomics of PCOS: from GWAS to molecular mechanisms
McAllister, J. M., Legro, R. S., Modi, B. P., & Strauss, J. F. (2015) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2014.12.004 · Cited by 227
Self-citation
Intracrine androgen biosynthesis, metabolism and action revisited
Schiffer, L., Arlt, W., & Storbeck, K.-H. (2018) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2017.08.016 · Cited by 217
“17b-hydroxysteroid dehydrogenase type 1, HSD17B1, is limited to the granulosa cells, where it activates E1 to E2 (Nelson et al., 2001).”
Polycystic ovary syndrome in adolescents
Franks, S. (2008) · International Journal of Obesity · doi:10.1038/ijo.2008.61 · Cited by 210
Ovarian Follicular Theca Cell Recruitment, Differentiation, and Impact on Fertility: 2017 Update
Richards, J. S., Ren, Y. A., Candelaria, N. R., Adams, J. E., & Rajkovic, A. (2017) · Endocrine Reviews · doi:10.1210/er.2017-00164 · Cited by 212
Valproate Potentiates Androgen Biosynthesis in Human Ovarian Theca Cells
Nelson-DeGrave, V. L., Wickenheisser, J. K., Cockrell, J. E., Wood, J. R., Legro, R. S., Strauss, J. F., & McAllister, J. M. (2003) · Endocrinology · doi:10.1210/en.2003-0940 · Cited by 184
Self-citation
Hyperandrogenism in polycystic ovarian syndrome and role of CYP gene variants: a review
Ashraf, S., Nabi, M., Rasool, S. U. A., Rashid, F., & Amin, S. (2019) · Egyptian Journal of Medical Human Genetics · doi:10.1186/s43042-019-0031-4 · Cited by 180
Alterations in Mitogen-Activated Protein Kinase Kinase and Extracellular Regulated Kinase Signaling in Theca Cells Contribute to Excessive Androgen Production in Polycystic Ovary Syndrome
Nelson-Degrave, V. L., Wickenheisser, J. K., Hendricks, K. L., Asano, T., Fujishiro, M., Legro, R. S., Kimball, S. R., Strauss, J. F., & McAllister, J. M. (2005) · Molecular Endocrinology · doi:10.1210/me.2004-0178 · Cited by 167
Self-citation
Genetics of polycystic ovary syndrome: searching for the way out of the labyrinth
Diamanti-Kandarakis, E., & Piperi, C. (2005) · Human Reproduction Update · doi:10.1093/humupd/dmi025 · Cited by 167
Structural and functional biology of aldo-keto reductase steroid transforming enzymes
Penning, T. M., Wangtrakuldee, P., & Auchus, R. J. (2019) · Endocrine Reviews · doi:10.1210/er.2018-00089 · Cited by 164
Self-citation
Involvement of androgens in ovarian health and disease
Lebbe, M., & Woodruff, T. K. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat065 · Cited by 165
The role of androgens in follicle maturation and ovulation induction: friend or foe of infertility treatment?
Gleicher, N., Weghofer, A., & Barad, D. H. (2011) · Reproductive Biology and Endocrinology · doi:10.1186/1477-7827-9-116 · Cited by 163
Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)
Palioura, E., & Diamanti-Kandarakis, E. (2015) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-016-9326-7 · Cited by 161
Polycystic ovary syndrome, adipose tissue and metabolic syndrome
Delitala, A. P., Capobianco, G., Delitala, G., Cherchi, P. L., & Dessole, S. (2017) · Archives of Gynecology and Obstetrics · doi:10.1007/s00404-017-4429-2 · Cited by 159
Endocrine and clinical effects of myo-inositol administration in polycystic ovary syndrome. A randomized study
Artini, P. G., Di Berardino, O. M., Papini, F., Genazzani, A. D., Simi, G., Ruggiero, M., & Cela, V. (2013) · Gynecological Endocrinology · doi:10.3109/09513590.2012.743020 · Cited by 154
Artemisinins ameliorate polycystic ovarian syndrome by mediating LONP1-CYP11A1 interaction
Liu, Y., Jiang, J., Du, S.-Y., Mu, L., Fan, J., Hu, J., Yao, Y., Ding, M., Zhou, W.-Y., Yu, Q., et al. (2024) · Science · doi:10.1126/science.adk5382 · Cited by 153
Polycystic Ovary Syndrome and Oocyte Developmental Competence
Dumesic, D. A., Padmanabhan, V., & Abbott, D. H. (2008) · Obstetrical & Gynecological Survey · doi:10.1097/ogx.0b013e31815e85fc · Cited by 144
Polycystic Ovary Syndrome in Adolescence
Buggs, C., & Rosenfield, R. L. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.04.005 · Cited by 147
Self-citation
Obesity and PCOS: The Effect of Metabolic Derangements on Endometrial Receptivity at the Time of Implantation
Schulte, M. B., Tsai, J.-H., & Moley, K. H. (2014) · Reproductive Sciences · doi:10.1177/1933719114561552 · Cited by 143
Risk of T2DM and impaired fasting glucose among pcos subjects: Results of an 8-year follow-up
Boudreaux, M. Y., Talbott, E. O., Kip, K. E., Brooks, M. M., & Witchel, S. F. (2006) · Current Diabetes Reports · doi:10.1007/s11892-006-0056-1 · Cited by 139
Hyperandrogenic origins of polycystic ovary syndrome-Implications for Pathophysiology and Therapy
Abbott, D. H., Dumesic, D. A., & Levine, J. E. (2019) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2019.1576522 · Cited by 131
The molecular signature of polycystic ovary syndrome (PCOS) theca cells defined by gene expression profiling
Wood, J. R., Ho, C. K. M., Nelson-DeGrave, V. L., McAllister, J. M., & Strauss, J. F. (2004) · Journal of Reproductive Immunology · doi:10.1016/j.jri.2004.01.010 · Cited by 130
Self-citation
Decreased myo-inositol to chiro-inositol (M/C) ratios and increased M/C epimerase activity in PCOS theca cells demonstrate increased insulin sensitivity compared to controls
Heimark, D. B., McAllister, J. M., & Larner, J. (2013) · Endocrine Journal · doi:10.1507/endocrj.ej13-0423 · Cited by 127
Self-citation
Implications of Polycystic Ovary Syndrome on Oocyte Development
Dumesic, D. A., & Abbott, D. H. (2008) · Seminars in Reproductive Medicine · doi:10.1055/s-2007-992925 · Cited by 127
The Role of TGF-β in Polycystic Ovary Syndrome
Raja-Khan, N. T., Urbanek, M., Rodgers, R. J., & Legro, R. S. (2013) · Reproductive Sciences · doi:10.1177/1933719113485294 · Cited by 132
Self-citation
Polycystic ovary syndrome and impact on health
Allahbadia, G. N., & Merchant, R. (2010) · Middle East Fertility Society Journal · doi:10.1016/j.mefs.2010.10.002 · Cited by 127
The genetics of polycystic ovary syndrome
Amato, P., & Simpson, J. L. (2004) · Best Practice & Research Clinical Obstetrics & Gynaecology · doi:10.1016/j.bpobgyn.2004.05.002 · Cited by 122
Differential expression of inflammation-related genes in the ovarian stroma and granulosa cells of PCOS women
Schmidt, J., Weijdegård, B., Mikkelsen, A., Lindenberg, S., Nilsson, L., & Brännström, M. (2013) · Molecular Human Reproduction · doi:10.1093/molehr/gat051 · Cited by 123
Ontogeny of the ovary in polycystic ovary syndrome
Dumesic, D. A., & Richards, J. S. (2013) · Fertility and Sterility · doi:10.1016/j.fertnstert.2013.02.011 · Cited by 118
Activation of arcuate nucleus GABA neurons promotes luteinizing hormone secretion and reproductive dysfunction: Implications for polycystic ovary syndrome
Silva, M. S. B., Desroziers, E., Hessler, S., Prescott, M., Coyle, C. S., Herbison, A. E., & Campbell, R. E. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.05.065 · Cited by 115
Dysregulation of Cytochrome P450 17α-Hydroxylase Messenger Ribonucleic Acid Stability in Theca Cells Isolated from Women with Polycystic Ovary Syndrome
Wickenheisser, J. K., Nelson-DeGrave, V. L., & McAllister, J. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2004-1860 · Cited by 115
Self-citation
Diagnosis and management of the dermatologic manifestations of the polycystic ovary syndrome
Lowenstein, E. J. (2006) · Dermatologic Therapy · doi:10.1111/j.1529-8019.2006.00077.x · Cited by 111
Proteomic analysis of human omental adipose tissue in the polycystic ovary syndrome using two-dimensional difference gel electrophoresis and mass spectrometry
Cortón, M., Botella-Carretero, J. I., López, J. A., Camafeita, E., Millán, J. L. S., Escobar-Morreale, H. F., & Peral, B. (2007) · Human Reproduction · doi:10.1093/humrep/dem380 · Cited by 112
Systems Genetics Reveals the Functional Context of PCOS Loci and Identifies Genetic and Molecular Mechanisms of Disease Heterogeneity
Jones, M. R., Brower, M. A., Xu, N., Cui, J., Mengesha, E., Chen, Y. I., Taylor, K. D., Azziz, R., & Goodarzi, M. O. (2015) · PLoS Genetics · doi:10.1371/journal.pgen.1005455 · Cited by 111
Polycystic Ovary Syndrome and Obstructive Sleep Apnea
Tasali, E., Cauter, E. V., & Ehrmann, D. A. (2008) · Sleep Medicine Clinics · doi:10.1016/j.jsmc.2007.11.001 · Cited by 111
Inositol as putative integrative treatment for PCOS
Genazzani, A. D. (2016) · Reproductive BioMedicine Online · doi:10.1016/j.rbmo.2016.08.024 · Cited by 106
Some New Thoughts on the Pathophysiology and Genetics of Polycystic Ovary Syndrome
Strauss, J. F. (2003) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1290.005 · Cited by 106
Self-citation
Simultaneous Measurement of Thirteen Steroid Hormones in Women with Polycystic Ovary Syndrome and Control Women Using Liquid Chromatography-Tandem Mass Spectrometry
Keefe, C. C., Goldman, M. M., Zhang, K., Clarke, N. J., Reitz, R. E., & Welt, C. K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0093805 · Cited by 105
The endocrine disruptor bisphenol A may play a role in the aetiopathogenesis of polycystic ovary syndrome in adolescent girls
Akın, L., Kendırcı, M., Narin, F., Kurtoğlu, S., Saraymen, R., Kondolot, M., Koçak, S. Ö., & Elmalı, F. (2014) · Acta Paediatrica · doi:10.1111/apa.12885 · Cited by 105
Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity
Rosenfield, R. L., & Bordini, B. (2010) · Brain Research · doi:10.1016/j.brainres.2010.08.088 · Cited by 101
Self-citation
Human ovarian theca cells in culture
Wickenheisser, J. K., Nelson-DeGrave, V. L., & McAllister, J. M. (2006) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2006.01.003 · Cited by 102
Self-citation
Genomic analysis using high-resolution single-nucleotide polymorphism arrays reveals novel microdeletions associated with premature ovarian failure
McGuire, M. M., Bowden, W., Engel, N. J., Ahn, H. W., Kovanci, E., & Rajkovic, A. (2011) · Fertility and Sterility · doi:10.1016/j.fertnstert.2010.12.052 · Cited by 102
Continuous Administration of a P450 Aromatase Inhibitor Induces Polycystic Ovary Syndrome with a Metabolic and Endocrine Phenotype in Female Rats at Adult Age
Maliqueo, M. A., Sun, M., Johansson, J., Benrick, A., Labrie, F., Svensson, H. G., Lönn, M., Dulęba, A. J., & Stener‐Victorin, E. (2012) · Endocrinology · doi:10.1210/en.2012-1693 · Cited by 104
Role of Oxidative Stress in Polycystic Ovary Syndrome
Lee, J. Y., Baw, C., Gupta, S., Aziz, N., & Agarwal, A. K. (2010) · Current Women s Health Reviews · doi:10.2174/157340410791321336 · Cited by 99
Uncovering steroidopathy in women with autism: a latent class analysis
Pohl, A., Cassidy, S., Auyeung, B., & Baron-Cohen, S. (2014) · Molecular Autism · doi:10.1186/2040-2392-5-27 · Cited by 97
Comparison of Ethinyl-Estradiol Plus Cyproterone AcetateVersusMetformin Effects on Classic Metabolic Cardiovascular Risk Factors in Women with the Polycystic Ovary Syndrome
Luque‐Ramírez, M., Álvarez‐Blasco, F., Botella-Carretero, J. I., Martínez‐Bermejo, E., Lasunción, M. A., & Escobar-Morreale, H. F. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0282 · Cited by 96
Dermatologic Manifestations of Polycystic Ovary Syndrome
Lee, A. T., & Zane, L. T. (2007) · American Journal of Clinical Dermatology · doi:10.2165/00128071-200708040-00003 · Cited by 98
Specific dermatologic features of the polycystic ovary syndrome and its association with biochemical markers of the metabolic syndrome and hyperandrogenism
Özdemir, S., Özdemir, M., Görkemli, H., Kıyıcı, A., & Bodur, S. (2010) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016340903353284 · Cited by 97
Genetic Variants Associated with Hyperandrogenemia in PCOS Pathophysiology
Dadachanji, R., Shaikh, N., & Mukherjee, S. (2018) · Genetics Research International · doi:10.1155/2018/7624932 · Cited by 90
Linkage of regulators of TGF‐β activity in the fetal ovary to polycystic ovary syndrome
Hatzirodos, N., Bayne, R. A. L., Irving‐Rodgers, H. F., Hummitzsch, K., Sabatier, L., Lee, S. S., Bonner, W. M., Gibson, M. A., Rainey, W. E., Carr, B. R., et al. (2011) · The FASEB Journal · doi:10.1096/fj.11-181099 · Cited by 90
Endocrine Disrupting Chemicals in Polycystic Ovary Syndrome: The Relevant Role of the Theca and Granulosa Cells in the Pathogenesis of the Ovarian Dysfunction
Józkowiak, M., Piotrowska‐Kempisty, H., Kobylarek, D., Gorska, N., Mozdziak, P. E., Kempisty, B., Rachoń, D., & Spaczyński, R. (2022) · Cells · doi:10.3390/cells12010174 · Cited by 94
Adiponectin and its receptors modulate granulosa cell and cumulus cell functions, fertility, and early embryo development in the mouse and human
Richards, J. S., Liu, Z., Kawai, T., Tabata, K., Watanabe, H., Suresh, D., Kuo, F., Pisarska, M. D., & Shimada, M. (2012) · Fertility and Sterility · doi:10.1016/j.fertnstert.2012.04.050 · Cited by 88
Identification of a Functional Polymorphism of the Human Type 5 17β-Hydroxysteroid Dehydrogenase Gene Associated with Polycystic Ovary Syndrome
Qin, K., Ehrmann, D. A., Cox, N. J., Refetoff, S., & Rosenfield, R. L. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-2012 · Cited by 84
Self-citation
Retinoids and Retinol Differentially Regulate Steroid Biosynthesis in Ovarian Theca Cells Isolated from Normal Cycling Women and Women with Polycystic Ovary Syndrome
Wickenheisser, J. K., Nelson-DeGrave, V. L., Hendricks, K. L., Legro, R. S., Strauss, J. F., & McAllister, J. M. (2005) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0330 · Cited by 82
Self-citation
Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS
Ryan, G. E., Malik, S., & Mellon, P. L. (2018) · Endocrinology · doi:10.1210/en.2017-03218 · Cited by 83
Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10
Chugh, R. M., Park, H.-S., Andaloussi, A. E., Elsharoud, A., Esfandyari, S., Ulin, M., Bakir, L. V., Aboalsoud, A., Ali, M. K., Ashour, D., et al. (2021) · Stem Cell Research & Therapy · doi:10.1186/s13287-021-02472-w · Cited by 80
Self-citation
Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats
Tyndall, V., Broyde, M., Sharpe, R. M., Welsh, M., Drake, A. J., & McNeilly, A. S. (2011) · Reproduction · doi:10.1530/rep-11-0239 · Cited by 80
Stromal Cells of the Human Postmenopausal Ovary Display a Distinctive Biochemical and Molecular Phenotype
Jabara, S. I., Christenson, L. K., Wang, C. Y., McAllister, J. M., Javitt, N. B., Dunaif, A. E., & Strauss, J. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021274 · Cited by 79
Self-citation
Ovarian Hypertension: Polycystic Ovary Syndrome
Bentley–Lewis, R., Seely, E. W., & Dunaif, A. E. (2011) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2011.01.009 · Cited by 83
The Disorders of Endometrial Receptivity in PCOS and Its Mechanisms
Jiang, N.-X., & Li, X. (2021) · Reproductive Sciences · doi:10.1007/s43032-021-00629-9 · Cited by 80
Genes and proteins of the alternative steroid backdoor pathway for dihydrotestosterone synthesis are expressed in the human ovary and seem enhanced in the polycystic ovary syndrome
Marti, N., Galván, J. A., Pandey, A. V., Trippel, M., Tapia, C., Müller, M., Perren, A., & Flück, C. E. (2017) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2016.07.029 · Cited by 76
A review of the hormones involved in the endocrine dysfunctions of polycystic ovary syndrome and their interactions
Emanuel, R. H. K., Roberts, J., Docherty, P. D., Lunt, H., Campbell, R. E., & Möller, K. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1017468 · Cited by 87
Pioglitazone Inhibits Androgen Production in NCI-H295R Cells by Regulating Gene Expression of CYP17 and HSD3B2
Kempná, P., Hofer, G., Mullis, P. E., & Flück, C. E. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.028902 · Cited by 73
Metabolic and endocrine effects of bisphenol A exposure in market seller women with polycystic ovary syndrome
Vahedi, M., Saeedi, A., Poorbaghi, S. L., Sepehrimanesh, M., & Fattahi, M. R. (2016) · Environmental Science and Pollution Research · doi:10.1007/s11356-016-7573-5 · Cited by 73
Expression profile of male germ cell‐associated genes in mouse embryonic stem cell cultures treated with all‐trans retinoic acid and testosterone
Silva, C., Wood, J. R., Salvador, L., Zhang, Z., Kostetskii, I., Williams, C. J., & Strauss, J. F. (2008) · Molecular Reproduction and Development · doi:10.1002/mrd.20925 · Cited by 71
Self-citation
Exercise for the treatment and management of overweight women with polycystic ovary syndrome: a review of the literature
Thomson, R. L., Buckley, J. D., & Brinkworth, G. D. (2011) · Obesity Reviews · doi:10.1111/j.1467-789x.2010.00758.x · Cited by 70
Implications of environmental toxicants on ovarian follicles: how it can adversely affect the female fertility?
Priya, K., Setty, M. M., Babu, U. V., & Pai, K. S. R. (2021) · Environmental Science and Pollution Research · doi:10.1007/s11356-021-16489-4 · Cited by 78
Early origins of polycystic ovary syndrome
Dumesic, D. A., Schramm, R. D., & Abbott, D. H. (2005) · Reproduction Fertility and Development · doi:10.1071/rd04092 · Cited by 67
Nesfatin-1 and other hormone alterations in polycystic ovary syndrome
Deniz, R., Gürateş, B., Aydın, S., Çelik, H., Şahin, İ., Baykuş, Y., Çatak, Z., Aksoy, A., Çitil, C., & Güngör, S. (2012) · Endocrine · doi:10.1007/s12020-012-9638-7 · Cited by 68
Introducing a rat model of prenatal androgen‐induced polycystic ovary syndrome in adulthood
Tehrani, F. R., Noroozzadeh, M., Zahediasl, S., Piryaei, A., & Azizi, F. (2014) · Experimental Physiology · doi:10.1113/expphysiol.2014.078055 · Cited by 68
KLF15 Is a Transcriptional Regulator of the Human 17β-Hydroxysteroid Dehydrogenase Type 5 Gene. A Potential Link between Regulation of Testosterone Production and Fat Stores in Women
Du, X., Rosenfield, R. L., & Qin, K. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-0139 · Cited by 67
Self-citation
Puberty and its disorders in the female
Rosenfield, R. L., Cooke, D. W., & Radovick, S. (2014) · Elsevier eBooks · doi:10.1016/b978-1-4557-4858-7.00024-x · Cited by 67
Self-citation
Selectivity determinants of the aldose and aldehyde reductase inhibitor-binding sites
El-Kabbani, O. A. L., & PODJARNY, A. D. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-6514-3 · Cited by 65
Hormonal Profile in Women with Polycystic Ovarian Syndrome with or without Type 1 Diabetes Mellitus
Ethel Codner, D., Íñiguez, G., Villarroel, C., López, P. V., Néstor Soto, I., Sir‐Petermann, T., CASSORLA, F. G., & Rey, R. A. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1252 · Cited by 65
Altered aquaporin expression in women with polycystic ovary syndrome: hyperandrogenism in follicular fluid inhibits aquaporin-9 in granulosa cells through the phosphatidylinositol 3-kinase pathway
Qu, F., Wang, F., Lu, X.-P., Dong, M. Y., Sheng, J., Lv, P. P., Ding, G., Shi, B., Zhang, D., & Huang, H. (2010) · Human Reproduction · doi:10.1093/humrep/deq078 · Cited by 64
Valproate Inhibits the Conversion of Testosterone to Estradiol and Acts as an Apoptotic Agent in Growing Porcine Ovarian Follicular Cells
Taubøll, E., Gregoraszczuk, E. Ł., Kołodziej, A., Kajta, M., & Ropstad, E. (2003) · Epilepsia · doi:10.1046/j.1528-1157.2003.60702.x · Cited by 64
Increased Cytochrome P450 17α-Hydroxylase Promoter Function in Theca Cells Isolated from Patients with Polycystic Ovary Syndrome Involves Nuclear Factor-1
Wickenheisser, J. K., Nelson-DeGrave, V. L., Quinn, P. G., & McAllister, J. M. (2003) · Molecular Endocrinology · doi:10.1210/me.2003-0090 · Cited by 63
Self-citation
Myo-Inositol in the Treatment of Teenagers Affected by PCOS
Pkhaladze, L., Barbakadze, L., & Kvashilava, N. (2016) · International Journal of Endocrinology · doi:10.1155/2016/1473612 · Cited by 62

Authors: Nelson, V. L., Qin, K.-N., Rosenfield, R. L., Wood, J. R., Penning, T. M., Legro, R. S., Strauss, J. F., & McAllister, J. M.
Affiliations: Departments of Cellular and Molecular Physiology (V.L.N., J.M.M.), Hershey, Pennsylvania 17033
Departments of Pediatrics and Medicine, University of Chicago (K.Q., R.L.R.), Chicago, Illinois 60637
Pennsylvania State University (US)
University of Pennsylvania (US)
ORCID: Rosenfield, Robert L.
Wood, Jennifer R.
Penning, Trevor M.
Legro, Richard S.
Strauss, Jerome F.
McAllister, Jan M.
Venue: The Journal of Clinical Endocrinology & Metabolism
Publisher: The Endocrine Society
Published: 2001-12-01
Volume: 86
Issue: 12
Pages: 5925-5933
ISSN: 0021-972X (ISSN-L)
1945-7197
DOI: 10.1210/jcem.86.12.8088
OpenAlex: W2062389660
Cited by: 405
References: 42
Citations by year: 2026: 12 · 2025: 10 · 2024: 8 · 2023: 8 · 2022: 16 · 2021: 33 · 2020: 13 · 2019: 17 · 2018: 16 · 2017: 14 · 2016: 13 · 2015: 15 · 2014: 23 · 2013: 20 · 2012: 24
FWCI: 9.65
Type: journal article
Language: en
Open access: closed
Locations: The Journal of Clinical Endocrinology & Metabolism (publishedVersion)
PubMed (publishedVersion)
Funders: National Institutes of Health
National Institute of Diabetes and Digestive and Kidney Diseases (DK-47015, R01DK047015)
National Center for Research Resources (RR-00055)
Eunice Kennedy Shriver National Institute of Child Health and Human Development (HD-34449, R01HD033852, HD 33852, HD-39267, HD 07305, U54HD034449, R01HD039267, HD-0118)
Topics: Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Sexual Differentiation and Disorders
Keywords: polycystic ovary syndrome, theca cells, testosterone production, 17β-hydroxysteroid dehydrogenase, AKR1C3, AKR1C1, 3β-hydroxysteroid dehydrogenase, steroidogenesis, androgen production, granulosa cells, enzyme activity
MeSH terms: Adult, Cells, Cultured, Female, Granulosa Cells, Humans, Hydroxysteroid Dehydrogenases, Isoenzymes, Ovary, Polycystic Ovary Syndrome, Reference Values, RNA, Messenger, Testosterone, Theca Cells, 20-Hydroxysteroid Dehydrogenases, 3-Hydroxysteroid Dehydrogenases, Reverse Transcriptase Polymerase Chain Reaction, 20-alpha-Hydroxysteroid Dehydrogenase

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The Biochemical Basis for Increased Testosterone Production in Theca Cells Propagated from Patients with Polycystic Ovary Syndrome

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks